[Subacute encephalopathy of early onset during treatment of relapse of lymphoblastosis in a young infant].
Donadio
A
A
Dossa
D
D
Montoya
F
F
Margueritte
G
G
Rieu
D
D
Navarro
M
M
Jean
R
R
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D001284:Atrophy; D001921:Brain / Q000187:drug effects / Q000473:pathology; D002531:Cerebellum / Q000473:pathology; D002552:Cerebral Ventricles / Q000473:pathology; D003131:Combined Modality Therapy; D016371:Cranial Irradiation / Q000009:adverse effects; D003561:Cytarabine / Q000008:administration & dosage / Q000009:adverse effects; D004827:Epilepsy / Q000209:etiology / Q000473:pathology; D006801:Humans; D007223:Infant; D007278:Injections, Spinal; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D008297:Male; D020258:Neurotoxicity Syndromes / Q000175:diagnosis / Q000209:etiology*; D010286:Paraventricular Hypothalamic Nucleus / Q000473:pathology; D012008:Recurrence; D012074:Remission Induction
D003561:Cytarabine